antigen
structur
transmiss
gastroenter
tge
viru
glycoprotein
defin
three
level
antigen
site
antigen
subsit
epitop
four
antigen
site
b
c
defin
competit
radioimmunoassay
ria
use
monoclon
antibodi
mab
select
fusion
hybridoma
specif
tge
viru
produc
neutral
mab
specif
site
one
antigen
domin
determin
site
differenti
three
antigen
subsit
b
c
character
mab
resist
mar
mutant
defin
mab
respect
subsit
subdivid
epitop
total
epitop
defin
glycoprotein
eight
critic
viru
neutral
neutral
mab
obtain
nativ
viru
use
immun
mice
although
produc
hybridoma
mice
immun
made
antigen
nativ
denatur
mixtur
nativ
denatur
form
neutral
mab
react
conform
epitop
antigen
structur
ezglycoprotein
defin
murin
mab
antigen
site
relev
swine
natur
host
viru
porcin
sera
react
site
mab
specif
tge
viru
site
c
react
nonimmun
porcin
sera
reactiv
direct
porcin
immunoglobulin
result
indic
tge
viru
contain
epitop
also
present
nonimmunoglobulin
compon
porcin
serum
transmiss
gastroenter
viru
swine
member
coronauiridu
famili
caus
diseas
gastrointestin
tract
produc
transitori
enter
adult
anim
mortal
anim
less
day
old
bohl
siddel
et
al
sturman
holm
viru
particl
spheric
diamet
nm
contain
lipid
envelop
posit
singlestrand
rna
approxim
kb
hu
et
al
kapk
brian
infecti
brian
et
al
viru
particl
compos
two
glycoprotein
el
one
nucleoprotein
n
glycoprotein
induc
neutral
antibodi
form
characterist
clubshap
project
particl
garw
et
al
jimcnez
et
al
effect
protect
swine
tge
viru
infect
induc
virul
strain
viru
moxley
olson
develop
effici
antitg
vaccin
synthet
genet
engin
requir
knowledg
immunogen
antigen
variabl
viru
ii
mechan
viru
neutral
iii
condit
induct
mammari
gut
immun
iv
clone
express
gene
code
protein
may
relev
induct
protect
previou
public
jimenez
et
al
describ
properti
six
epitop
critic
tge
viru
neutral
articl
describ
antigen
structur
glycoprotein
three
level
defin
antigen
site
antigen
subsit
epitop
base
competit
radioimmunoassay
ria
character
monoclon
antibodi
resist
mar
mutant
present
inform
natur
accomplish
antigen
character
tge
viru
larg
collect
tge
viru
posit
hybridoma
use
attempt
obtain
repres
data
character
mab
abl
recogn
sequenti
determin
differ
antigen
site
interestingli
domin
site
tge
viru
neutral
subdivid
three
antigen
subsit
addit
crossreact
one
antigen
site
tge
viru
compon
porcin
sera
describ
epitheli
swine
testicl
cell
line
st
develop
mcclurkin
norman
obtain
dr
kemeni
nation
anim
diseas
center
ame
iowa
cell
grown
monolay
growth
medium
consist
dulbecco
modifi
eagl
dme
medium
gibco
europ
newborn
calf
serum
flow
laboratori
inc
balbc
mice
origin
obtain
ra
fox
frederick
cancer
research
center
frederick
md
use
immun
sourc
thymocyt
periton
macrophag
purdu
strain
tge
viru
pur
plaqu
purifi
grown
st
cell
describ
previous
jimenez
et
al
virul
miller
strain
pass
swine
wesley
wood
kindli
provid
r
wesley
nation
anim
diseas
center
ame
iowa
tge
viru
plaqu
isol
viru
titrat
st
cell
previous
describ
jimenez
et
al
plaqu
reduct
assay
perform
incub
tge
viru
phosphatebuff
salin
pb
foetal
calf
serum
presenc
hybridoma
supernat
min
dilut
lofold
virusmab
mixtur
dme
medium
contain
foetal
calf
serum
pg
deaedextran
per
ml
pharmacia
carri
portion
contain
dilut
appli
cell
h
viru
adsorpt
inoculum
replac
medium
contain
foetal
calf
serum
pg
deaedextran
per
ml
agaros
cell
incub
c
day
humidifi
incub
cell
fix
formaldehyd
stain
crystal
violet
plaqu
count
neutral
index
determin
divid
number
pfu
viru
per
millilit
mix
normal
serum
number
pfu
viru
per
millilit
presenc
mous
antiserum
purifi
tge
viru
st
cell
grown
roller
bottl
incub
viru
multipl
infect
pfu
per
cell
viru
clarifi
cultur
supemat
concentr
centrifug
h
rpm
c
sorvail
rotor
ww
sucros
cushion
tri
hydrochloridel
mm
disodium
nacl
ph
supplement
tween
sediment
dilut
buffer
supplement
tween
sediment
ww
sucros
gradient
centrifug
h
rpm
c
sorval
rotor
fraction
contain
viru
pool
dilut
one
volum
buffer
sediment
rotor
h
rpm
c
radioimmunoassay
tge
viru
protein
pg
per
well
pb
adsorb
polyvinyl
dispos
u
plate
dynatech
laboratori
inc
overnight
incub
c
subsequ
step
assay
perform
describ
sanz
et
al
use
second
antiserum
mous
immunoglobulin
specif
rabbit
antiserum
amplifi
reaction
protein
develop
assay
competit
ria
mab
purifi
high
pressur
liquid
chromatographi
hplc
ascit
fluid
deschamp
et
al
greenwod
et
al
inhibit
bind
purifi
viru
unlabel
mab
studi
singl
step
competit
ria
briefli
bovin
serum
albumin
pb
per
well
ad
viru
coat
plate
indic
plate
incub
h
c
fivefold
dilut
unlabel
mab
pb
contain
bsa
mix
mab
x
cpm
per
well
specif
activ
cpm
per
pg
immunoglobulin
incub
h
c
antigenco
well
plate
wash
six
time
buffer
describ
supplement
tween
well
cut
radioact
determin
minigamma
counter
wallac
lkb
obtain
hybridoma
secret
tge
virusspecif
mab
cell
mous
myeloma
cell
line
kearni
et
al
fuse
spleen
cell
balbc
mice
immun
purifi
nativ
denatur
nativ
denatur
viru
summar
tabl
denatur
viru
obtain
incub
sodium
dodecyl
sulfat
sd
nonidet
min
boil
water
indic
see
tabl
second
incub
min
c
presenc
trichloroacet
acid
perform
character
hybridoma
fusion
describ
previous
jimcnez
et
al
character
hybridoma
fusion
describ
select
antigen
variant
resist
neutral
specif
mab
mar
mutant
thirteen
mab
perform
incub
pfu
tge
viru
purdu
strain
ml
pb
foetal
calf
serum
one
volum
hybridoma
supernat
st
cell
monolay
grow
petri
dish
inocul
ml
portion
lofold
dilut
virusmab
mixtur
incub
h
c
ad
agar
overlay
contain
volum
correspond
hybridoma
supernat
per
dish
diamet
mm
costar
day
infect
viru
plaqu
collect
select
procedur
carri
two
time
mar
mutant
isol
neutral
less
homolog
mab
wherea
neutral
origin
viru
time
frequenc
mar
mutant
defin
invers
number
pfu
viru
neutral
mab
per
pfu
resist
neutral
mab
assay
perform
biodot
microfiltr
apparatu
biorad
laboratori
use
nitrocellulos
membran
transblot
transfer
membran
cat
biorad
laboratori
basic
procedur
hawk
et
al
follow
briefli
nativ
denatur
purifi
tge
viru
pg
per
well
bound
nitrocellulos
paper
prewash
min
pb
buffer
viru
denatur
incub
boil
water
min
sd
pb
denatur
viru
dilut
lofold
pb
bound
nitrocellulos
paper
incub
sampl
h
room
temperatur
filtrat
vacuum
block
solut
bsa
pb
per
well
ad
incub
h
filter
one
hundredfold
dilut
mous
serum
pb
contain
bsa
undilut
hybridoma
supemat
ad
incub
continu
overnight
c
well
wash
pb
supplement
tween
use
vacuum
nitrocellulos
membran
remov
microfiltr
apparatu
incub
h
room
temperatur
presenc
wv
nonfat
dri
milk
molico
nestl
pb
dilut
peroxidaseconjug
rabbit
antimous
immunoglobulin
heavi
light
chain
cappel
laboratori
pb
supplement
bsa
ad
incub
h
filter
wash
color
develop
solut
mg
per
ml
methanol
five
vol
h
pb
hawk
et
al
ad
incub
continu
optimum
stain
obtain
bind
polyclon
mab
viral
protein
transfer
nitrocellulos
paper
perform
method
towbin
et
al
minor
modif
briefli
protein
separ
sdspage
laemmli
absenc
presenc
gel
equilibr
methanol
mm
tri
mm
glycin
ph
protein
electrophoret
transfer
nitrocellulos
membran
filter
transfer
nitrocellulos
membran
wash
mm
mm
tri
hydrochlorid
ph
incub
continu
wash
buffer
see
contain
nonfat
dri
milk
satur
remain
protein
bind
site
membran
incub
hybridoma
supernat
dilut
antiserum
wash
buffer
see
contain
nonfat
dri
milk
overnight
band
specif
recogn
develop
techniqu
hawk
et
al
incub
peroxidaselabel
rabbit
antiserum
specif
mous
immunoglobulin
total
hybridoma
tge
viru
posit
deriv
independ
cell
cell
fusion
event
cell
clone
immedi
hybridoma
format
obtain
differ
fusion
hybridoma
growth
observ
well
suggest
statist
one
hybridoma
per
well
tabl
summar
antigen
administ
immtmiz
balbc
mice
use
fusion
durat
immun
titr
sera
mice
provid
immun
cell
number
hybridoma
posit
ria
produc
neutral
mab
characterist
mab
first
fusion
describ
previous
jimenez
et
al
fusion
mab
posit
ria
tge
viru
base
high
titr
ria
select
mab
secret
hybridoma
clone
least
three
time
sixteen
neutral
viru
infect
neutral
mab
specif
glycoprotein
recogn
epitop
sensit
denatur
sd
plu
order
induc
specif
neutral
mab
would
abl
recogn
antigen
determin
repres
major
immunodomin
site
resist
denatur
fusion
perform
use
cell
mice
immun
nativ
viru
alon
fusion
nativ
denatur
viru
fusion
last
three
fusion
mab
initi
select
base
high
titr
ria
test
neutral
assay
mab
posit
ie
neutral
viru
infect
loofold
twenti
neutral
mab
select
hybridoma
clone
three
time
studi
whether
mab
secret
fusion
abl
recogn
sequenti
determin
reactiv
nativ
denatur
tge
viru
analyz
immunodot
assay
tabl
although
mab
recogn
nativ
viru
none
neutral
mab
react
denatur
viru
reactiv
mab
tge
viru
immunodot
immunoblot
assay
analyz
treatment
differ
sd
concentr
indic
pattern
reactiv
differ
two
system
tabl
mab
two
neutral
laflo
four
nonneutr
react
iunoblot
treatment
sd
wherea
mab
show
strong
weak
reactiv
immunodot
similar
treatment
initi
studi
interfer
unlabel
mab
purifi
hplc
bind
ezspecif
mab
tge
viru
onestep
competit
ria
studi
perform
possibl
pair
mab
direct
bind
inhibit
curv
shown
fig
obtain
mab
inhibit
bind
homolog
one
differ
degre
competit
illustr
repres
mab
obtain
one
mab
block
bind
complet
fig
partial
figur
result
bidirect
competit
ria
process
mab
inhibit
bind
assign
antigen
site
figur
show
summari
result
four
antigen
site
name
b
c
could
differenti
site
defin
mab
respect
interestingli
neutral
mab
map
site
convers
mab
site
neutral
extend
studi
neutral
mab
select
fusion
inhibit
bind
mab
repres
site
site
lbhll
site
b
site
c
site
supernat
hybridoma
studi
figur
show
result
typic
competit
ria
neutral
mab
last
three
fusion
inhibit
bind
mab
repres
site
bind
repres
site
b
c
indic
react
site
epitop
two
mab
select
fusion
respect
repres
fig
repres
accord
criteria
competit
z
eq
site
addit
mab
select
repres
site
b
respect
collect
mar
mutant
fig
obtain
isol
frequenc
rang
lo
two
mab
lbbll
possibl
isol
mar
mutant
neutral
viru
use
pfu
per
assay
indic
frequenc
put
mar
mutant
lower
character
mutant
collect
glycoproteinspecif
mab
show
lack
neutral
mar
mutant
mab
use
select
mab
differ
one
use
isol
mar
fig
suggest
mab
recogn
epitop
locat
antigen
subsit
antigen
area
alter
mar
mutant
result
permit
group
mab
three
set
mab
defin
three
subsit
design
b
c
respect
subsit
addit
one
defin
largest
number
mab
modifi
mar
mutant
mab
reduc
mar
mutant
plaqu
determin
plaqu
reduct
assay
neutral
neutral
determin
competit
ria
relev
differenti
characterist
determin
typif
mar
mutant
nd
determin
na
applic
relev
differenti
characterist
determin
studi
reactiv
mab
immunoblot
immunoadsorpt
assay
nonidet
sd
sodium
dodecyl
sulfat
zmercaptoethanol
sensit
sensit
relev
differenti
characterist
determin
abil
mab
neutral
toy
strain
tge
viru
presenc
absenc
f
partial
modifi
nd
determin
relev
differenti
characterist
determin
mur
mutant
isol
nd
determin
relev
differenti
characterist
size
suggest
modifi
epitop
recogn
mab
partial
mar
mutant
sinc
mab
use
defin
antigen
subsit
locat
site
antigen
structur
protein
base
result
competit
ria
character
mar
mutant
could
repres
diagrammat
shown
fig
data
obtain
competit
ria
well
mar
mutant
character
resist
deterg
determin
presenc
natur
isol
jimenez
et
al
mar
mutant
isol
frequenc
led
us
defin
minimum
epitop
glycoprotein
critic
neutral
tge
viru
tabl
next
studi
relev
antigen
site
defin
tge
viru
infect
swine
natur
host
studi
whether
differ
glycoprotein
antigen
site
defin
murin
mab
also
recogn
swine
antisera
inbit
bind
glycoproteinspecif
mab
tge
viru
specif
polyclon
swine
antisera
infect
immun
anim
determin
studi
perform
six
mab
repres
four
antigen
c
site
protein
lbbll
high
low
rel
avid
respect
data
shown
site
site
b
site
c
site
result
fig
indic
three
swine
antisera
test
inhibit
bind
mab
repres
four
antigen
site
unexpect
result
control
antisera
also
inhibit
bind
two
mab
specif
antigen
site
c
bind
mab
specif
antigen
site
determin
whether
inhibit
site
cspecif
mab
bind
due
occup
bind
site
normal
swine
serum
mediat
reactiv
tge
viru
direct
reactiv
label
mab
serum
competit
ria
perform
follow
two
protocol
first
one
swine
serum
label
mab
incub
simultusli
virusco
well
second
one
serum
incub
first
plate
wash
remov
unbound
serum
label
mab
ad
inhibit
bind
mab
observ
first
case
suggest
block
due
reactiv
mab
sera
noniun
anim
studi
reactiv
mab
direct
immunoglobulin
present
sera
analyz
inhibit
bind
mab
viru
ria
purifi
porcin
immunoglobuhn
result
shown
indic
porcin
iunoglobun
inhibit
bind
suggest
reactiv
direct
compon
porcin
sera
antigen
structur
glycoprotein
tge
viru
determin
use
tge
viru
posit
hybridoma
select
independ
celltocel
fusion
event
base
data
percentag
well
hybridoma
growth
consid
statist
conclus
deal
monoclon
reagent
nevertheless
hybridoma
first
fusion
fusion
clone
least
three
time
mab
repres
antigen
domin
site
obtain
introduc
character
mar
mutant
subdivid
critic
antigen
site
smaller
antigen
area
defin
antigen
subsit
probabl
repres
domain
viru
surfac
physic
differenti
four
antigen
site
b
c
defin
competit
ria
neutral
mab
specif
site
mab
secret
larg
proport
around
posit
hybridoma
analyz
clone
condit
well
contain
statist
around
one
hybridoma
per
well
result
suggest
critic
site
one
antigen
domin
agreement
previou
result
enjuan
et
al
delma
et
al
also
identifi
immunodomin
site
tge
viru
neutral
studi
neutral
tge
viru
pur
strain
mab
induc
miller
strain
viru
provid
r
wood
r
wesley
mab
neutral
revers
pur
strain
tge
viru
probabl
low
avid
inhibitth
bind
mab
repres
antigen
site
b
c
correa
r
wood
r
wesley
l
enjuan
unpublish
result
data
indic
either
tge
viru
minor
critic
epitop
distinct
site
mab
react
also
critic
site
due
low
avid
inhibit
bind
site
repres
mab
epitop
site
probabl
critic
viru
neutral
mab
react
site
neutral
area
must
conformationdepend
sinc
none
neutral
mab
recogn
viral
protein
denatur
sd
plu
tabl
ii
neither
viru
glycoprotein
denatur
differ
procedur
induc
neutral
polyclon
monoclon
antibodi
tabl
jimcnez
et
al
although
discard
possibl
exist
mab
abl
recogn
primari
structur
unabl
isol
mab
type
select
mab
type
unlik
due
lack
neutral
polyval
antisera
induc
denatur
viru
interestingli
mab
repres
site
b
c
react
glycoprotein
partial
denatur
sd
might
use
physic
differenti
peptid
repres
antigen
site
tabl
fig
antigen
site
glycoprotein
defin
competit
ria
fig
competit
perform
direct
case
interfer
bind
pair
mab
reciproc
either
inhibit
block
bind
observ
except
detect
fig
could
explain
differ
avid
mab
altern
explan
would
case
inhibit
bind
one
mab
due
chang
conform
epitop
recogn
mab
conform
chang
reciproc
character
mar
mutant
made
possibl
differenti
site
glycoprotein
three
antigen
subsit
b
c
subsit
repres
area
viru
surfac
could
independ
modifi
form
differenti
antigen
domain
critic
viru
neutral
could
basi
select
differ
peptid
use
synthet
subunit
vaccin
viral
system
alter
detect
surfac
mur
mutant
relat
wild
type
viru
shown
due
singl
amino
acid
chang
consequ
chang
singl
nucleotid
whenev
sequenc
mar
mutant
determin
seif
et
al
vandepol
et
al
vanwyk
coelingh
et
al
yewdel
et
al
possibl
correl
function
subsit
viru
surfac
small
fragment
tge
viru
genom
determin
nucleic
acid
sequenc
antigen
structur
tge
viru
subdivid
epitop
use
mab
differ
properti
total
epitop
defin
glycoprotein
critic
epitop
locat
site
reciproc
epitop
defin
site
critic
indic
antigen
site
viru
untouch
antibodi
without
inactiv
viru
number
epitop
defin
glycoprotein
rel
molecular
weight
order
number
defin
well
character
virus
one
epitop
fragment
rel
molecular
weight
jackson
et
al
niman
elder
stone
nowinski
epitop
defin
murin
mab
glycoprotein
relev
natur
host
porcin
sera
infect
immun
swine
react
four
antigen
site
defin
competit
ria
mab
mab
react
antigen
site
c
also
react
undetermin
nonimmunoglobulin
compon
swine
sera
thu
tge
viru
infect
could
induc
autoimmun
respons
could
produc
immunocomplex
diseas
chronic
infect
anim
oldston
